Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

3,734 total articles

Boston Properties Executive Sells $328K in Stock Amid Stock Weakness; Q4 Beat, Analyst Downgrade Add Mixed Signals

Boston Properties Executive Sells $328K in Stock Amid Stock Weakness; Q4 Beat, Analyst Downgrade Add Mixed Signals

Boston Properties Executive Vice President Hilary J. Spann sold 5,495 shares on February 27, 2026, generating $327,996 at prices between $59.18 and $59.77. The transaction, disclosed on an SEC Form 4, leaves Spann with 17,832 shares. The sale occurs as BXP stock trades below recent levels and after a fourth-quarter earnings beat; a recent analyst d…

Birchtech CEO Buys $750,000 of Stock as Company Prices $15M Offering and Seeks $78M Judgment Payment

Birchtech CEO Buys $750,000 of Stock as Company Prices $15M Offering and Seeks $78M Judgment Payment

Birchtech Corp.'s chief executive acquired 312,500 shares worth $750,000 as the company concurrently priced a 6,250,000-share offering at $2.40 per share and moved to collect a $78 million judgment following the expiration of a 30-day stay of execution. The trades and corporate actions come as the stock trades near its 52-week low and shows recent …

Palvella Therapeutics Director Buys $500,000 of Stock Amid Upsized Offering and Positive Phase 3 News

Palvella Therapeutics Director Buys $500,000 of Stock Amid Upsized Offering and Positive Phase 3 News

A Palvella Therapeutics director bought $500,000 of company stock on February 27, 2026, joining a period of intense corporate activity that included an upsized public offering and a bullish analyst update tied to positive phase 3 data for the company’s QTORIN Rapamycin treatment. The transaction and recent financing highlight simultaneous insider c…

Palvella Director Acquires $300,000 in Stock Amid Company Offering

Palvella Director Acquires $300,000 in Stock Amid Company Offering

A Palvella Therapeutics director purchased $300,000 worth of company stock in connection with a recently closed underwritten offering. The transaction, disclosed on a Form 4, coincides with a large public share sale that generated $230 million in gross proceeds and an analyst upgrade following positive phase 3 data for the company’s QTORIN Rapamyci…

Wayfair CEO Sells $2.13 Million in Stock Amid Mixed Analyst Views

Wayfair CEO Sells $2.13 Million in Stock Amid Mixed Analyst Views

Wayfair Chief Executive Officer Niraj Shah sold 27,300 shares of Class A common stock on February 26, 2026, for roughly $2.13 million under a previously adopted Rule 10b5-1 trading plan. The transactions, disclosed on a Form 4 filing with the SEC, come as the shares have risen 93% over the past year but are down 24% year-to-date. The company report…

LPL Financial CFO Sells Stake as Company Posts Strong Q4 Results and Announces Strategic Partnership

LPL Financial CFO Sells Stake as Company Posts Strong Q4 Results and Announces Strategic Partnership

Matthew J. Audette, president and chief financial officer of LPL Financial Holdings Inc. (NASDAQ: LPLA), sold 1,581 shares on February 26, 2026 under a pre-existing Rule 10b5-1 plan, generating approximately $506,715. The transactions, disclosed on a Form 4, were part of a set of moves that also included share dispositions to cover taxes and cost-f…

Live Oak Bancshares CEO Completes $786,998 Sale of 20,000 Shares

Live Oak Bancshares CEO Completes $786,998 Sale of 20,000 Shares

Live Oak Bancshares Chief Executive Officer James S. Mahan III sold 20,000 shares of the company’s voting common stock across February 25 and 26, 2026, via trades executed through the James S. Mahan Revocable Trust and carried out under a Rule 10b5-1 plan adopted Aug. 27, 2025. The disposals totaled $786,998. The stock has declined over 11% in the …

Walton Family Holdings Trust Sells $220 Million in Walmart Shares, Analysts Raise Targets on Digital Momentum

Walton Family Holdings Trust Sells $220 Million in Walmart Shares, Analysts Raise Targets on Digital Momentum

The Walton Family Holdings Trust, which holds roughly 10% of Walmart, sold 1,723,736 shares of Walmart Inc. for about $220 million in multiple transactions on Feb. 26-27, 2026. The sales ranged from $127.1188 to $128.0593 per share; the trust still directly owns 522,580,949 shares. Several brokerages have recently raised price targets on Walmart, p…